Drug · DIN 02519968
PEMAZYRE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 26, 2021; first marketed November 26, 2021.
- Drug Identification Number (DIN)
- 02519968
- Company (DIN owner)
- Incyte CorporationWilmington, Delaware, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Pemigatinib L01EN02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PEMIGATINIB | 13.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 17, 2021: NOC 26673New Drug Submission (NDS)
Other DINs named PEMAZYRE
- DIN 02519933 · Marketed
- DIN 02519941 · Marketed